Last reviewed · How we verify
Secondary malignant neoplasm of pancreas
Approved treatments
- Taxol · Pfizer
Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. - Camptosar · Pfizer
Irinotecan and its metabolite SN-38 bind to the topoisomerase I-DNA complex, preventing DNA repair and causing double-strand breaks. - Taxol · Pfizer
- Camptosar · Pfizer
Camptosar works by blocking the enzyme topoisomerase I, which is necessary for DNA replication, thereby preventing cancer cells from dividing and growing. - Camptosar · Pfizer
Camptosar works by inhibiting topoisomerase I, an enzyme that helps DNA replicate, causing DNA damage and cancer cell death. - Taxol · Pfizer
- Abraxane · The First Affiliated Hospital with Nanjing Medical University
- Taxol · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Secondary malignant neoplasm of pancreas patent landscape — cliff calendar, originator estates, attackable patents
- Secondary malignant neoplasm of pancreas treatment landscape brief
- Secondary malignant neoplasm of pancreas treatment updates RSS
Frequently asked questions about Secondary malignant neoplasm of pancreas
What drugs treat Secondary malignant neoplasm of pancreas?
Tracked treatments include Taxol, Camptosar, Abraxane.
What is the treatment for Secondary malignant neoplasm of pancreas?
Standard treatment for Secondary malignant neoplasm of pancreas includes Taxol, Camptosar, Abraxane. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Secondary malignant neoplasm of pancreas patent cliff · Secondary malignant neoplasm of pancreas CI report
- Treatment: Taxol · Pfizer
- Treatment: Camptosar · Pfizer
- Treatment: Taxol · Pfizer
- Treatment: Camptosar · Pfizer
- Treatment: Camptosar · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing